Sign in
Download Opera News App

HEALTH COVID

BenevolentAI: Data from Eli Lilly's COV-BARRIER trial shows baricitinib reduced deaths in hospitalised COVID-19 patients by 38%

BenevolentAI: Data from Eli Lilly's COV-BARRIER trial shows baricitinib reduced deaths in hospitalised COVID-19 patients by 38%

The latest data published in Eli Lilly's Phase 3 randomised, double-blind, placebo-controlled study (COV-BARRIER) shows the largest clinical effect reported to date for a reduction in mortality in the COVID-19 patient population Early in the pandemic, BenevolentAI researchers identified Baricitinib as a potential treatment for COVID-19 and published the hypothesis in...

Read Full Story
ACTT-2 AI Baricitinib BenevolentAI Eli Lilly FDA

Top News

GOSSIP CELEBRITY

Kate Middleton is poised to step up in the family: Duchess of Cambridge was dignified and composed as she arrived at the castle alone and chose an outfit that was 'elegant but not overstated,' fashion experts reveal

dailymail.co.uk
Kate Middleton is poised to step up in the family: Duchess of Cambridge was dignified and composed as she arrived at the castle alone and chose an outfit that was 'elegant but not overstated,' fashion experts reveal

GOSSIP CELEBRITY

Kate Middleton is poised to step up in the family: Duchess of Cambridge was dignified and composed as she arrived at the castle alone and chose an outfit that was 'elegant but not overstated,' fashion experts reveal

dailymail.co.uk

GOSSIP CELEBRITY

Nick Knowles blasts BBC over Wills and Harry funeral comments

grimsbytelegraph.co.uk
Nick Knowles blasts BBC over Wills and Harry funeral comments

GOSSIP CELEBRITY

Nick Knowles blasts BBC over Wills and Harry funeral comments

grimsbytelegraph.co.uk

comments

Load app to read more comments